Concepedia

Wei‐Tien Tai

WT

Statistics

Publications

35

Citations

2.2K

H-Index

26

Active since

2010

Affiliations

National Taiwan University Hospital(Current)

National Yang Ming Chiao Tung University

Taipei Veterans General Hospital

National Taiwan University

Wei‐Tien Tai is an author at National Taiwan University Hospital specializing in oncology, pharmacology, and molecular oncology.

Publications per year

2010–2023

35

Publications

35

Activation of Phosphatidylinositol 3-Kinase/Akt Signaling Pathway Mediates Acquired Resistance to Sorafenib in Hepatocellular Carcinoma Cells

Kuen‐Feng Chen, Hui‐Ling Chen, Wei‐Tien Tai et al. · Journal of Pharmacology and Experimental Therapeutics · 2011 · 319 citations

, , +17

Sorafenib Overcomes TRAIL Resistance of Hepatocellular Carcinoma Cells through the Inhibition of STAT3

Kuen‐Feng Chen, Wei‐Tien Tai, Tsung‐Hao Liu et al. · Clinical Cancer Research · 2010 · 170 citations

, , +17

Signal transducer and activator of transcription 3 is a major kinase-independent target of sorafenib in hepatocellular carcinoma

Wei‐Tien Tai, Ann‐Lii Cheng, Chung-Wai Shiau et al. · Journal of Hepatology · 2011 · 157 citations

, , +17

Dovitinib Induces Apoptosis and Overcomes Sorafenib Resistance in Hepatocellular Carcinoma through SHP-1–Mediated Inhibition of STAT3

Wei‐Tien Tai, Ann‐Lii Cheng, Chung-Wai Shiau et al. · Molecular Cancer Therapeutics · 2011 · 121 citations · Full text

, , +17

STAT3 Mediates Regorafenib-Induced Apoptosis in Hepatocellular Carcinoma

Wei‐Tien Tai, Pei‐Yi Chu, Chung‐Wai Shiau et al. · Clinical Cancer Research · 2014 · 100 citations

, , +16

1–5 of 35